CRL Charles River Laboratories (CRL) Q1 FY26 earnings call
Charles River Laboratories reported Q1 FY26 results in line with expectations, with organic revenue declining slightly amidst anticipated margin pressures. The company is focused on its 'Pathway to Purpose' strategic framework, emphasizing modernization, scientific portfolio strengthening, and client-centricity. Management anticipates significant operating margin expansion in the second half of the year, driven by strategic acquisitions, divestitures, and efficiency initiatives, with a clear line of sight to achieving its full-year guidance.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
CRL operating KPIs by quarter
| KPI | This call Mar 2026 Q1 FY26 | Jun 2026 Q2 FY26 | Change vs prior quarter |
|---|---|---|---|
| Backlog DSA | $1.92BAs previously mentioned, we are encouraged that the overall DSA demand environment is tracking to our expectation, resulting in a net book-to-bill of 1.04x and a slight sequential increase in backlog to $1.92 billion at the end of the first quarter.Source: earnings call transcript | $1.97BNet bookings increased significantly year-over-year and by 12.6% sequentially to $701 million in the second quarter resulting in an increase in the DSA backlog to $1.97 billion and a net book-to-bill of 1.9x.Source: earnings call transcript | +2.6% |
| Net bookings | $622MNet bookings totaled a solid $622 million, remaining above the $600 million threshold, driven by continued strength from our small and mid-sized biotech client base.Source: earnings call transcript | $701MNet bookings increased significantly year-over-year and by 12.6% sequentially to $701 million in the second quarter resulting in an increase in the DSA backlog to $1.97 billion and a net book-to-bill of 1.9x.Source: earnings call transcript | +12.7% |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.